Dyadic International, Inc. (NASDAQ:DYAI) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET
Company Participants
Ping Rawson – Chief Financial Officer
Mark Emalfarb – President and Chief Executive Officer
Joe Hazelton – Chief Business Officer
Conference Call Participants
John Vandermosten – Zacks SCR
Lewis Titterton – Private Investor
Operator
Good evening and welcome to Dyadic International’s Third Quarter Fiscal 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode. Following management’s prepared remarks, there will be a brief question-and-answer session. As a reminder, this conference is being recorded today, November 10, 2022.
I'd now like to turn the call over to Ms. Ping Rawson, Dyadic’s Chief Financial Officer. Please go ahead, ma'am.
Ping Rawson
Thank you. Good evening and welcome everyone to Dyadic International's third quarter fiscal 2022 conference call. I hope you have had opportunity to review Dyadic's press release announcing financial results for the quarter ended September 30, 2022 and the recent company highlights. You may access our release and Form 10-Q under the Investors section of the company's website at dyadic.com.
On today's call, our President and CEO, Mark Emalfarb will give a review of our third quarter 2022 business and corporate highlights, including a brief summary of our research and the business development efforts. Our Chief Business Officer, Joe Hazelton will join Mark for the business update. I will follow with a review of our financial results in more detail. We'll then hold a brief Q&A session.
At this time, I would like to inform you that certain commentary made in this conference call may be considered forward-looking statements, which involves risks and uncertainties and other factors that could cause Dyadic's actual results performance, scientific or otherwise, or achievements to be materially different from those expressed or implied by these forward-looking statements.
Dyadic expressly disclaims any duty to provide updates to its forward-looking statements whether as a result of new information future events or otherwise. Participants are directed to the risk factors set forth in Dyadic's reports filed with the SEC.
It is now my pleasure to pass the call to our CEO, Mark Emalfarb. Mark?
Mark Emalfarb
Thank you, Ping. Hello everyone and thank you for joining Dyadic's third quarter update call. As you will hear on today's call, we are continuing to advance our scientific developments and there is much to be excited about at Dyadic. In Q2, we discussed the company's focus on our core business in achieving commercial agreements in each of its three core verticals, human health, animal health, and alternative proteins.